Feature Slides
Discovering New Therapeutic Uses for Existing Molecules
NCATS unveils new program that matches researchers with more than 20 pharmaceutical industry compounds to help scientists explore new treatments for patients.
Designing a Tissue Chip for Drug Screening
NCATS is spearheading the quest for a better way to identify which candidate drugs and devices are most likely to become approved therapeutics.
New Drug for Rare Type of Cystic Fibrosis
Ten institutions funded by Clinical and Translational Science Awards helped develop the first targeted therapy for a rare type of cystic fibrosis.
NCATS Teams Up with Eli Lilly
A new collection of comprehensive information about medicines could lead to new and different uses for medicines that already exist.
RESEARCH HIGHLIGHTS
News & Events
- AesRX Anti-Sickling Drug Aes-103 Enters Phase 1/2a Clinical Trial at NIH • AesRx
- Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat • Scripps Health
- Anantha Shekhar Elected President of Association for Clinical and Translational Science • Indiana University School of Medicine
- More News & Events...
Social Media Links